BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Davidson B, Micci F. Molecular characteristics of uterine sarcomas. Expert Rev Mol Diagn 2017;17:515-22. [PMID: 28335657 DOI: 10.1080/14737159.2017.1311790] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Dundr P, Gregová M, Hojný J, Krkavcová E, Michálková R, Němejcová K, Bártů M, Hájková N, Laco J, Mára M, Richtárová A, Zima T, Stružinská I. Uterine cellular leiomyomas are characterized by common HMGA2 aberrations, followed by chromosome 1p deletion and MED12 mutation: morphological, molecular, and immunohistochemical study of 52 cases. Virchows Arch 2021. [PMID: 34626221 DOI: 10.1007/s00428-021-03217-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Tavares M, Khandelwal G, Mutter J, Viiri K, Beltran M, Brosens JJ, Jenner RG. JAZF1-SUZ12 dysregulates PRC2 function and gene expression during cell differentiation.. [DOI: 10.1101/2021.04.15.440052] [Reference Citation Analysis]
3 Alabiad MA, Harb OA, Abdelfattah MT, El-shafaay BS, El-taher AK, El-hendawy EI. The values of Transgelin, Stathmin, BCOR and Cyclin-D1 expression in differentiation between Uterine Leiomyosarcoma (ULMS) and Endometrial Stromal Sarcoma (ESS); diagnostic and prognostic implications. Surg Exp Pathol 2020;3. [DOI: 10.1186/s42047-020-00065-0] [Reference Citation Analysis]
4 Davidson B, Matias-Guiu X, Lax SF. The clinical, morphological, and genetic heterogeneity of endometrial stromal sarcoma. Virchows Arch 2020;476:489-90. [PMID: 31993772 DOI: 10.1007/s00428-020-02762-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Li Y, Ren H, Wang J. Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study. BMC Cancer 2019;19:697. [PMID: 31307426 DOI: 10.1186/s12885-019-5879-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
6 Micci F, Davidson B. Molecular Genetics of Uterine Sarcomas. eLS 2019. [DOI: 10.1002/9780470015902.a0028464] [Reference Citation Analysis]
7 Tantari M, Barra F, Di Domenico S, Ferraioli D, Vellone VG, De Cian F, Ferrero S. Current state of the art and emerging pharmacotherapy for uterine leiomyosarcomas. Expert Opinion on Pharmacotherapy 2019;20:713-23. [DOI: 10.1080/14656566.2019.1571042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kyriazoglou A, Liontos M, Ziogas DC, Zagouri F, Koutsoukos K, Tsironis G, Tsiara A, Kaparelou M, Zakopoulou R, Thomakos N, Haidopoulos D, Papaspyrou I, Rodolakis A, Bamias A, Dimopoulos MA. Management of uterine sarcomas and prognostic indicators: real world data from a single-institution. BMC Cancer 2018;18:1247. [PMID: 30541504 DOI: 10.1186/s12885-018-5156-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
9 Zappacosta R, Fanfani F, Zappacosta B, Sablone F, Pansa L, Liberati M, Rosini S. Uterine Sarcomas: An Updated Overview. Part 1: Smooth Muscle Tumors. Neoplasm 2018. [DOI: 10.5772/intechopen.76772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Gantzer J, Ray-coquard I. Gynecological sarcomas: what's new in 2018, a brief review of published literature. Current Opinion in Oncology 2018;30:246-51. [DOI: 10.1097/cco.0000000000000462] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
11 Tsuyoshi H, Yoshida Y. Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma. Cancer Sci 2018;109:1743-52. [PMID: 29660202 DOI: 10.1111/cas.13613] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
12 Chang CC, Huang LH, Chiang W, Hsia SM. Hexane fraction of adlay (Coix lachryma-jobi L.) testa ethanolic extract inhibits human uterine sarcoma cancer cells growth and chemosensitizes human uterine sarcoma cells to doxorubicin. Phytomedicine 2018;47:69-80. [PMID: 30166110 DOI: 10.1016/j.phymed.2018.03.056] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
13 Brunetti M, Panagopoulos I, Gorunova L, Davidson B, Heim S, Micci F. RNA-sequencing identifies novel GREB1-NCOA2 fusion gene in a uterine sarcoma with the chromosomal translocation t(2;8)(p25;q13). Genes Chromosomes Cancer 2018;57:176-81. [PMID: 29218853 DOI: 10.1002/gcc.22518] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
14 Busca A, Parra-Herran C. Myxoid Mesenchymal Tumors of the Uterus: An Update on Classification, Definitions, and Differential Diagnosis. Adv Anat Pathol 2017;24:354-61. [PMID: 28787279 DOI: 10.1097/PAP.0000000000000164] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]